ADEL-Y03

N/A

Report date: 2023/10/10 11:30:43

Base Information

Drug NameADEL-Y03
Drug Alias NameADEL-Y03
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Beta-2-microglobulin
TargetsBeta-2-microglobulin
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesADEL Inc
China Registration ClassN/A

Develop Information

Active CompaniesADEL Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A